FierceBiotech

Francis Medical collects $80M to carry water vapor ablation for prostate cancer to the FDA

Francis Medical has obtained $80 million in venture capital funding to support the development of its water vapor ablation therapy for cancers of the prostate, kidneys and bladder. The series C round ...
Morningstar

Francis Medical Announces First Commercial Procedure with the Vanquish® Water Vapor System for Prostate Tissue Ablation

MINNEAPOLIS, Feb. 3, 2026 /PRNewswire/ -- Francis Medical, Inc., a privately-held medical device company, announced the first commercial procedure using the Vanquish Water Vapor Ablation System at ...
MarketWatch

Francis Medical Receives FDA 510(k) Clearance for Use of the Vanquish(R) Water Vapor System for Prostate Tissue Ablation in Patients with Intermediate Risk Prostate Cancer

The MarketWatch News Department was not involved in the creation of this content. MINNEAPOLIS, Dec. 2, 2025 /PRNewswire/ -- Francis Medical, Inc., a privately-held medical device company developing ...
AOL

Does Medicare cover Aquablation for benign prostatic hyperplasia?

Medicare Part B covers Aquablation for BPH if a person meets specific eligibility criteria, including a prostate volume of 30 to 150 cubic centimeters (cc). Medicare does not cover Aquablation in ...
News Medical

Ablation Technology: Innovations and Industry Overview

Ablation therapy consists of a minimally invasive treatment, which can be used for treating cancer by destroying tumors and other abnormal tissues within the body. It uses either extremely high or low ...
Morningstar

Francis Medical Receives FDA 510(k) Clearance for Use of the Vanquish® Water Vapor System for Prostate Tissue Ablation in Patients with Intermediate Risk Prostate Cancer

MINNEAPOLIS, Dec. 2, 2025 /PRNewswire/ -- Francis Medical, Inc., a privately-held medical device company developing the breakthrough Vanquish® Water Vapor Ablation System for the management of ...